https://arstechnica.com/tech-policy/2021/09/theranos-promised-investors-1b-in-revenue-despite-internal-projection-of-just-100m/

Around the time that Theranos was losing nearly $2 million per week, investors in the blood-testing startup were being told that the company would soon be bringing in almost $1 billion per year.

It’s not uncommon for startups to lose money in their early years, and it’s not entirely unusual for the fastest burn rate to happen right before things turn around. Instead, Theranos continued to produce mounting losses. But that’s not what the company was telling investors, according to new documents shared during the jury trial of Theranos founder and CEO Elizabeth Holmes.